NASDAQ:RAIN Rain Oncology (RAIN) Stock Price, News & Analysis → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free RAIN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$1.21▼$1.2150-Day Range$1.20▼$1.2452-Week Range$0.82▼$11.32VolumeN/AAverage Volume550,818 shsMarket Capitalization$44.02 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media Get Rain Oncology alerts: Email Address Ad Smallcaps DailyThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WayNanoviricides Technology Will Transform The Way Viruses & Their Variants Are Treated Worldwide And This Company Is At The Forefront!See how with its ongoing expansion and development About Rain Oncology Stock (NASDAQ:RAIN)As of January 26, 2024, operates as a subsidiary of Pathos AI, Inc.Read More Ad Smallcaps DailyThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WayNanoviricides Technology Will Transform The Way Viruses & Their Variants Are Treated Worldwide And This Company Is At The Forefront!See how with its ongoing expansion and development RAIN Stock News HeadlinesMay 16 at 9:36 AM | yahoo.comCancer Survivors Are Sharing The Symptom That Finally Made Them Go To The DoctorMay 13 at 5:19 PM | finance.yahoo.comAdvertising Agency PPK Aims to Fight Pediatric Cancer with Children's Book Raising Funds for the National Pediatric Cancer FoundationMay 12, 2024 | msn.comWhat to know ahead of this weekend's Avera Race Against CancerMay 11, 2024 | msn.comTrumbull County Relay for Life raises money for American Cancer SocietyMay 7, 2024 | msn.comKing Charles III is 'very good' amid cancer treatment, won't see Harry during prince's U.K. visitMay 7, 2024 | sports.yahoo.comRain forces changes to YAIAA baseball and softball tournament datesMay 6, 2024 | msn.comScott Dunlap declared PGA Tour Champions winner after final round washed outMay 6, 2024 | washingtonpost.comDunlap declared PGA Tour Champions winner after rain washes out final roundMay 5, 2024 | yahoo.com‘Rick’s Fun Run’ helps teacher battling cancerMay 5, 2024 | msn.comThousands brave rain for 27th annual Race for Hope DCMay 3, 2024 | msn.comBreast cancer survivors beat the rain during Kentucky Oaks Day Survivors ParadeMay 3, 2024 | msn.comLIVE UPDATES: Clouds, rain don't dampen spirits on Oaks Day at Churchill DownsMay 2, 2024 | msn.comWeather Impact Day: Heavy rain, possible thunderstorms on SaturdayMay 2, 2024 | msn.comJohnson & Johnson wants to pay $6.5B to settle talcum-powder lawsuits over cancer claimsMay 2, 2024 | yahoo.comWatch David Gilmour wring every ounce of emotion from the guitar solo on Prince's Purple Rain – with Tom JonesMay 1, 2024 | msn.comTalking to your kids about child abuseMay 1, 2024 | msn.comBeloved WSU dog dies after valiant battle with cancerMay 1, 2024 | msn.comBBC Strictly Come Dancing's Amy Dowden says 'I never wanted' and issues career announcement after cancer fightMay 1, 2024 | uk.news.yahoo.com‘I want to walk the equivalent of a marathon every week’ – Allyson, 60, sets herself a charity challenge after twice being treated for cancerApril 30, 2024 | msn.comBBC Strictly Come Dancing's Amy Dowden 'can't believe it' as she shares major news after cancer treatmentApril 30, 2024 | msn.comAmy Dowden announces book offering ‘solace and inspiration’ after cancer battleApril 29, 2024 | msn.comWinner of US$1.3 billion Powerball jackpot is an immigrant from Laos who has cancerApril 29, 2024 | msn.comAlarm Frontman Mike Peters Reveals New Cancer Diagnosis, Band Postpones 2024 North American TourApril 29, 2024 | msn.com$1.3B Powerball winner is Laos-born immigrant battling cancerApril 29, 2024 | msn.comRain is in Friday's forecast. What to expect for Kentucky Oaks 2024 at Churchill DownsSee More Headlines Receive RAIN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rain Oncology and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/10/2021Today5/16/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolNASDAQ:RAIN CUSIPN/A CIK1724979 Webwww.rainthera.com Phone510-953-5559FaxN/AEmployees63Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-75,720,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-82.96% Return on Assets-68.31% Debt Debt-to-Equity RatioN/A Current Ratio5.58 Quick Ratio5.58 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$3.11 per share Price / Book0.39Miscellaneous Outstanding Shares36,380,000Free Float30,047,000Market Cap$44.02 million OptionableOptionable Beta0.27 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Avanish Vellanki M.B.A. (Age 49)Co-Founder, CEO & Chairman Comp: $959.75kDr. Robert C. Doebele M.D. (Age 53)Ph.D., Co-Founder, Chairman of Scientific Advisory Board, President & CSO and Chief Medical Officer Comp: $700.56kMs. Josephine Bruce (Age 45)Principal Financial & Accounting officer Ms. Theresa O'Connell M.S.Director of Corporate Development & OperationsMr. Erik Atkisson (Age 52)General Counsel & Chief Compliance Officer Ms. Charmi TurnerVice President of People & CultureMs. Vijaya Tirunagaru Ph.D.Senior VP & Head of ResearchDr. Nora Ku M.D.MD & VP of Clinical DevelopmentMore ExecutivesKey CompetitorsLianBioNASDAQ:LIANGain TherapeuticsNASDAQ:GANXLENSARNASDAQ:LNSRDyadic InternationalNASDAQ:DYAIOcuphire PharmaNASDAQ:OCUPView All CompetitorsInsidersKevin C TangSold 40,132 sharesTotal: $48,559.72 ($1.21/share)Kevin C TangSold 109,435 sharesTotal: $131,322.00 ($1.20/share)Kevin C TangBought 131,631 shares on 10/13/2023Total: $130,314.69 ($0.99/share)Kevin C TangBought 74,812 shares on 10/11/2023Total: $72,567.64 ($0.97/share)Kevin C TangBought 333,325 shares on 6/1/2023Total: $369,990.75 ($1.11/share)View All Insider Transactions RAIN Stock Analysis - Frequently Asked Questions Should I buy or sell Rain Oncology stock right now? 10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Rain Oncology in the last twelve months. There are currently 10 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" RAIN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RAIN, but not buy additional shares or sell existing shares. View RAIN analyst ratings or view top-rated stocks. How were Rain Oncology's earnings last quarter? Rain Oncology Inc. (NASDAQ:RAIN) posted its quarterly earnings results on Wednesday, November, 10th. The company reported ($0.70) EPS for the quarter, missing analysts' consensus estimates of ($0.64) by $0.06. When did Rain Oncology IPO? Rain Oncology (RAIN) raised $126 million in an initial public offering (IPO) on Friday, April 23rd 2021. The company issued 7,400,000 shares at $16.00-$18.00 per share. Goldman Sachs, Citigroup, Piper Sandler and Guggenheim Securities served as the underwriters for the IPO. This page (NASDAQ:RAIN) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden to Drop BOMBSHELL June 13th?Paradigm PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThis Wall Street stock prediction just went viralChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rain Oncology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.